Jonathan Livingstone-Banks

Working with the Cochrane Tobacco Addiction Group, I manage and coordinate the preparation and publication of systematic reviews that investigate the effectiveness of different ways to help people to stop smoking, and to prevent them from smoking in the first place. I am also a research fellow on the NIHR funded project: 'Behavioural interventions for smoking cessation', a suite of Cochrane reviews including an overview of reviews and network meta-analyses with covariates informed by updates of existing Cochrane reviews.

The Cochrane Tobacco Addiction Group (TAG) is part of Cochrane, an international not-for-profit and independent organization, dedicated to producing and disseminating up-to-date, accurate information about the effects of healthcare worldwide. 

Tobacco is still the single largest cause of preventable death, killing approximately seven million people each year. Cochrane TAG produces systematic reviews of the evidence on interventions to prevent and treat tobacco addiction, and public policy interventions for reducing smoking prevalence. We also manage a small suite of reviews on food allergy interventions and transgender health.

I'm also a philosopher interested in the philosophy of medicine; in particular how we define and classify diseases and how this impacts on healthcare practice and medical research.